{"id":"https://openalex.org/W174689142","doi":null,"title":"[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].","display_name":"[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W174689142","mag":"174689142","pmid":"https://pubmed.ncbi.nlm.nih.gov/12498034"},"language":"hu","primary_location":{"id":"pmid:12498034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12498034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica Hungarica","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048598916","display_name":"L\u00e1szl\u00f3 D\u00e9zsi","orcid":"https://orcid.org/0000-0002-4190-9793","observed_orcids":["https://orcid.org/0000-0002-4190-9793"]},"institutions":[{"id":"https://openalex.org/I2808169635","display_name":"Gedeon Richter (Hungary)","ror":"https://ror.org/0033rtn64","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"L\u00e1szl\u00f3 D\u00e9zsi","raw_affiliation_strings":["Richter Gedeon Vegy\u00e9szeti Gy\u00e1r Rt., Budapest, Gy\u00f6mr\u00f3i \u00fat 19-21.-1103"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Richter Gedeon Vegy\u00e9szeti Gy\u00e1r Rt., Budapest, Gy\u00f6mr\u00f3i \u00fat 19-21.-1103","institution_ids":["https://openalex.org/I2808169635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025744426","display_name":"Istv\u00e1nn\u00e9 Kis-Varga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Istv\u00e1nn\u00e9 Kis-Varga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100914621","display_name":"J\u00f3zsef Nagy","orcid":"https://orcid.org/0000-0002-0729-0683","observed_orcids":["https://orcid.org/0000-0002-0729-0683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J\u00f3zsef Nagy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081595509","display_name":"Zsolt Koml\u00f3di","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zsolt Koml\u00f3di","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112187159","display_name":"Egon K\u00e1rp\u00e1ti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Egon K\u00e1rp\u00e1ti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"72","issue":"2","first_page":"84","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vinpocetine","display_name":"vinpocetine","score":1.0},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.9980000257492065},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9290000200271606},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.9879999756813049},{"id":"https://openalex.org/keywords/excitotoxicity","display_name":"excitotoxicity","score":0.9549999833106995},{"id":"https://openalex.org/keywords/glutamate-excitotoxicity","display_name":"glutamate excitotoxicity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8059999942779541},{"id":"https://openalex.org/keywords/veratridine","display_name":"veratridine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/nimodipine","display_name":"nimodipine","score":0.9290000200271606},{"id":"https://openalex.org/keywords/flunarizine","display_name":"flunarizine","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cortical-neurons","display_name":"cortical neurons","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C2778788455","wikidata":"https://www.wikidata.org/wiki/Q420288","display_name":"Vinpocetine","level":2,"score":0.9897812604904175},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9032225608825684},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7639236450195312},{"id":"https://openalex.org/C2777286116","wikidata":"https://www.wikidata.org/wiki/Q416237","display_name":"Flunarizine","level":3,"score":0.7585160732269287},{"id":"https://openalex.org/C2777294900","wikidata":"https://www.wikidata.org/wiki/Q421429","display_name":"Nimodipine","level":3,"score":0.686577320098877},{"id":"https://openalex.org/C2781012912","wikidata":"https://www.wikidata.org/wiki/Q901117","display_name":"Excitotoxicity","level":4,"score":0.6223259568214417},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5797350406646729},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.5172491669654846},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5066946148872375},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41864609718322754},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37907081842422485},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11653584241867065},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.10818719863891602},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09343037009239197},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07835820317268372},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002546","descriptor_name":"Ischemic Attack, Transient","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014748","descriptor_name":"Vinca Alkaloids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014748","descriptor_name":"Vinca Alkaloids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12498034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12498034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica Hungarica","raw_type":"English Abstract"},{"id":"mag:174689142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12498034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2141945873","https://openalex.org/W2325348809","https://openalex.org/W2418851572","https://openalex.org/W7138314356","https://openalex.org/W2017321150","https://openalex.org/W3007542949","https://openalex.org/W2042493512","https://openalex.org/W7095565380","https://openalex.org/W2089496439","https://openalex.org/W4379618762"],"abstract_inverted_index":{"The":[0,60],"aim":[1],"of":[2,15,24,33,62,108,162,168,176,204],"the":[3,12,22,34,57,106,159,202],"present":[4],"study":[5],"was":[6,71,103,164,172],"to":[7,29,100,174],"review":[8],"neuroprotective":[9,31,160,194],"therapy":[10,203],"from":[11],"preclinical":[13],"point":[14],"view":[16],"as":[17,26,28,126],"a":[18],"potential":[19,195],"tool":[20],"for":[21],"treatment":[23,89],"stroke,":[25],"well":[27],"discuss":[30],"effects":[32,54],"apovincaminic":[35,189],"acid":[36,190],"derivative":[37],"vinpocetine":[38,63,163],"(Cavinton).":[39],"Our":[40],"own":[41],"in":[42,45,56,73,80,118,201],"vivo":[43],"and":[44,140],"vitro":[46],"experiments":[47],"were":[48,116],"aimed":[49],"at":[50],"further":[51],"characterizing":[52],"pharmacological":[53],"involved":[55],"vinpocetine-induced":[58],"neuroprotection.":[59],"effect":[61,107],"on":[64],"infarct":[65,92],"volume":[66,93],"(obtained":[67],"by":[68],"2,3,5-triphenyltetrazolium-chloride":[69],"staining)":[70],"studied":[72],"permanent":[74],"middle":[75],"cerebral":[76],"artery":[77],"occlusion":[78],"(MCAO)":[79],"rats":[81],"(3":[82],"mg/kg":[83],"i.p.,":[84],"30":[85],"min":[86],"postischemia).":[87],"Vinpocetine":[88,129],"significantly":[90],"decreased":[91],"(by":[94],"42%,":[95],"p":[96],"<":[97],"0.05)":[98],"compared":[99],"control,":[101],"which":[102],"better":[104],"than":[105,166],"nimodipine":[109],"(17%)":[110],"or":[111,135,144,178],"MK-801":[112],"(18%).":[113],"Neurotoxicity":[114],"measurements":[115],"made":[117],"primary":[119],"cortical":[120],"cell":[121],"culture":[122],"using":[123],"LDH":[124],"release":[125],"an":[127,198],"indicator.":[128],"dose-dependently":[130],"inhibited":[131],"prolonged":[132],"(24":[133],"h)":[134],"transient":[136,141],"(15":[137],"min)":[138],"glutamate,":[139],"N-metil-D-aspartate":[142],"(NMDA)":[143],"veratridine":[145],"(0.1-1":[146],"mM)":[147],"induced":[148],"excitotoxicity":[149],"(IC50":[150],"=":[151],"2-7":[152],"x":[153],"10(-6)":[154],"M).":[155],"In":[156],"these":[157],"tests":[158],"potency":[161],"lower":[165],"that":[167,188],"MK-801,":[169],"but":[170],"it":[171],"similar":[173],"those":[175],"flunarizine":[177],"nimodipine.":[179],"These":[180],"results":[181],"together":[182],"with":[183],"former":[184],"literature":[185],"data":[186],"indicate":[187],"derivatives":[191],"possessing":[192],"strong":[193],"may":[196],"play":[197],"important":[199],"role":[200],"ischemic":[205],"stroke.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}